» Articles » PMID: 32793332

Inflammatory Response in Postmenopausal Osteoporotic Fracture Healing

Overview
Journal Bone Joint Res
Date 2020 Aug 15
PMID 32793332
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

A balanced inflammatory response is important for successful fracture healing. The response of osteoporotic fracture healing is deranged and an altered inflammatory response can be one underlying cause. The objectives of this review were to compare the inflammatory responses between normal and osteoporotic fractures and to examine the potential effects on different healing outcomes. A systematic literature search was conducted with relevant keywords in PubMed, Embase, and Web of Science independently. Original preclinical studies and clinical studies involving the investigation of inflammatory response in fracture healing in ovariectomized (OVX) animals or osteoporotic/elderly patients with available full text and written in English were included. In total, 14 articles were selected. Various inflammatory factors were reported; of those tumour necrosis factor-α (TNF-α) and interleukin (IL)-6 are two commonly studied markers. Preclinical studies showed that OVX animals generally demonstrated higher systemic inflammatory response and poorer healing outcomes compared to normal controls (SHAM). However, it is inconclusive if the local inflammatory response is higher or lower in OVX animals. As for clinical studies, they mainly examine the temporal changes of the inflammatory stage or perform comparison between osteoporotic/fragility fracture patients and normal subjects without fracture. Our review of these studies emphasizes the lack of understanding that inflammation plays in the altered fracture healing response of osteoporotic/elderly patients. Taken together, it is clear that additional studies, preclinical and clinical, are required to dissect the regulatory role of inflammatory response in osteoporotic fracture healing. Cite this article: 2020;9(7):368-385.

Citing Articles

The interactions of macrophages, lymphocytes, and mesenchymal stem cells during bone regeneration.

Murayama M, Chow S, Lee M, Young B, Ergul Y, Shinohara I Bone Joint Res. 2024; 13(9):462-473.

PMID: 39237112 PMC: 11377107. DOI: 10.1302/2046-3758.139.BJR-2024-0122.R1.


Is human immunodeficiency virus a risk factor for the development of nonunion?-a case-control study.

Graham S, Maqungo S, Laubscher M, Ferreira N, Held M, Harrison W OTA Int. 2023; 6(2):e251.

PMID: 37780185 PMC: 10538559. DOI: 10.1097/OI9.0000000000000251.


Inflammatory Processes Affecting Bone Health and Repair.

Torres H, Arnold K, Oviedo M, Westendorf J, Weaver S Curr Osteoporos Rep. 2023; 21(6):842-853.

PMID: 37759135 PMC: 10842967. DOI: 10.1007/s11914-023-00824-4.


Glycolytic reprogramming in macrophages and MSCs during inflammation.

Li X, Shen H, Zhang M, Teissier V, Huang E, Gao Q Front Immunol. 2023; 14:1199751.

PMID: 37675119 PMC: 10477714. DOI: 10.3389/fimmu.2023.1199751.


Astragalus polysaccharide promotes osteogenic differentiation of human bone marrow derived mesenchymal stem cells by facilitating ANKFY1 expression through miR-760 inhibition.

Hu X, Yang L, Du Y, Meng X, Shi Y, Zeng J Bone Joint Res. 2023; 12(8):476-485.

PMID: 37532241 PMC: 10396440. DOI: 10.1302/2046-3758.128.BJR-2022-0248.R2.


References
1.
Pfeilschifter J, Koditz R, Pfohl M, Schatz H . Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 2002; 23(1):90-119. DOI: 10.1210/edrv.23.1.0456. View

2.
Loi F, Cordova L, Pajarinen J, Lin T, Yao Z, Goodman S . Inflammation, fracture and bone repair. Bone. 2016; 86:119-30. PMC: 4833637. DOI: 10.1016/j.bone.2016.02.020. View

3.
Metzger C, Narayanan S . The Role of Osteocytes in Inflammatory Bone Loss. Front Endocrinol (Lausanne). 2019; 10:285. PMC: 6527760. DOI: 10.3389/fendo.2019.00285. View

4.
Karnes J, Daffner S, Watkins C . Multiple roles of tumor necrosis factor-alpha in fracture healing. Bone. 2015; 78:87-93. DOI: 10.1016/j.bone.2015.05.001. View

5.
Meyer U, de Jong J, Bours S, Keszei A, Arts J, Brink P . Early changes in bone density, microarchitecture, bone resorption, and inflammation predict the clinical outcome 12 weeks after conservatively treated distal radius fractures: an exploratory study. J Bone Miner Res. 2014; 29(9):2065-73. DOI: 10.1002/jbmr.2225. View